Skip to main content

Table 3 Median antifilarial IgG levels for the 126 persons in the Mapou cohort who received antifilarial drug treatment in 2000 and the 34 who did not, by year

From: Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence

  

Antifilarial Antibody Level*

Treatment status

 

2000

2001

 

Received treatment

 

Median (interquartile range)

Median (interquartile range)

p-value

 

IgG1

68.5 (22.2–147.5)

43.0 (20.9–85.6)

0.001

 

IgG4

57.5 (29.9–98.3)

55.9 (21.0–65.9)

0.067

Did not receive treatment

    
 

IgG1

64.5 (31.9–157.0)

100.0 (52.3–169.7)

0.101

 

IgG4

61.5 (45.6–104.6)

96.4 (52.40–216.0)

0.088

  1. *units